Gilead Sciences, Inc (NASDAQ:GILD) has a beta value of 0.35 and has seen 1.22 million shares traded in the recent trading session. The company, currently valued at $136.02B, closed the recent trade at $109.34 per share which meant it lost -$2.75 on the day or -2.45% during that session. The GILD stock price is -9.71% off its 52-week high price of $119.96 and 35.79% above the 52-week low of $70.21. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.98 million shares traded. The 3-month trading volume is 8.46 million shares.
The consensus among analysts is that Gilead Sciences, Inc (GILD) is Buy stock at the moment, with a recommendation rating of 1.83. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 6 out of 17 have rated it as a Hold, with 11 advising it as a Buy. 0 have rated the stock as Underweight.
Gilead Sciences, Inc (NASDAQ:GILD) trade information
Sporting -2.45% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the GILD stock price touched $109.34 or saw a rise of 4.81%. Year-to-date, Gilead Sciences, Inc shares have moved 56.27%, while the 5-day performance has seen it change -1.55%. Over the past 30 days, the shares of Gilead Sciences, Inc (NASDAQ:GILD) have changed -2.41%. Short interest in the company has seen 22.99 million shares shorted with days to cover at 2.85.
Wall Street analysts have a consensus price target for the stock at $126, which means that the shares’ value could jump 13.22% from the levels at last check today.. The projected low price target is $114.0 while the price target rests at a high of $135.0. In that case, then, we find that the latest price level in today’s session is -23.47% off the targeted high while a plunge would see the stock gain -4.26% from the levels at last check today..
Gilead Sciences, Inc (GILD) estimates and forecasts
The company’s shares have gained 21.66% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -38.13% over the past 5 years. Earnings growth for 2025 is a modest 73.01% while over the next 5 years, the company’s earnings are expected to increase by 26.07%.
GILD Dividends
Gilead Sciences, Inc is expected to release its next earnings report on 2025-Apr-24 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 3.12 at a share yield of 2.85%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 3.95%.
Gilead Sciences, Inc (NASDAQ:GILD)’s Major holders
Insiders own 0.10% of the company shares, while shares held by institutions stand at 89.60% with a share float percentage of 89.70%. Investors are also buoyed by the number of investors in a company, with Gilead Sciences, Inc having a total of 2706.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 120.63 million shares worth more than $8.28 billion. As of 2024-06-30, BLACKROCK INC. held 9.6738% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 115.26 million shares as of 2024-06-30. The firm’s total holdings are worth over $7.91 billion and represent 9.2431% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund . As of Mar 31, 2025 , the former fund manager holds about 3.16% shares in the company for having 39.37 shares of worth $4.29 billion while later fund manager owns 34.63 shares of worth $3.77 billion as of Mar 31, 2025 , which makes it owner of about 2.78% of company’s outstanding stock.
